BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12012751)

  • 1. [Star disease: diabetic nephropathy].
    Cordonnier D
    Nephrologie; 2002; 23(2):73-6. PubMed ID: 12012751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetic nephropathy: physiopathology and clinical course].
    Macía Heras M; Macía Jerez M; Coronel F
    Nefrologia; 2001; 21 Suppl 3():24-31. PubMed ID: 11642203
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of progression of nephropathy in a population-based sample with type 2 diabetes.
    Vupputuri S; Nichols GA; Lau H; Joski P; Thorp ML
    Diabetes Res Clin Pract; 2011 Feb; 91(2):246-52. PubMed ID: 21156326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index in type 2 diabetes mellitus complications: hypertensive diabetics and diabetic nephropathy.
    Idogun ES; Unuigbe EI; Famodu AA; Akinola OT
    Niger Postgrad Med J; 2006 Mar; 13(1):17-20. PubMed ID: 16633373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal structure and function in type 2 diabetic patients with or without diabetic nephropathy.
    Christensen PK
    Dan Med Bull; 2004 Feb; 51(1):82-103. PubMed ID: 16009073
    [No Abstract]   [Full Text] [Related]  

  • 7. An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea.
    Kim DM; Ahn CW; Park JS; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S169-72. PubMed ID: 15563971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on nephropathy in type 2 diabetes mellitus: histology and its correlation with clinical and biochemical parameters.
    Bhattacharya S; Mandal SK; Bandyopadhyay R; Chakrabarti S; Basu AK; Pal S
    J Indian Med Assoc; 2007 Oct; 105(10):592, 594-6. PubMed ID: 18383954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
    Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria prevalence study in hypertensive type 2 diabetic patients in Malaysia.
    Kong NC; Chia YC; Khalid BA; Juwita S; Samiah Yasmin AK; Yap LY; Norlaila M; Menon J; Tan C; Fung YK;
    Med J Malaysia; 2006 Oct; 61(4):457-65. PubMed ID: 17243524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered vascular homeostasis in type 2 diabetic nephropathy.
    Futrakul N; Butthep P; Futrakul P
    Ren Fail; 2009; 31(3):207-10. PubMed ID: 19288326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes: response to Shultis et al.
    Varon FN
    Diabetes Care; 2007 Dec; 30(12):e138; author reply e139. PubMed ID: 18042747
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease.
    Stehouwer CD
    Nephrol Dial Transplant; 2004 Apr; 19(4):778-81. PubMed ID: 15031329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type 1 and 2 diabetes in children and adults. Third part: diabetic complications].
    Timsit J; Dubois-Laforgue D
    Rev Prat; 2003 Oct; 53(15):1693-700. PubMed ID: 14689919
    [No Abstract]   [Full Text] [Related]  

  • 18. Mouse models of diabetic nephropathy.
    Breyer MD; Böttinger E; Brosius FC; Coffman TM; Harris RC; Heilig CW; Sharma K;
    J Am Soc Nephrol; 2005 Jan; 16(1):27-45. PubMed ID: 15563560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephropathy in the course of non-insulin-dependent diabetes mellitus].
    Czech A; Bernaś M
    Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):4-6. PubMed ID: 8008676
    [No Abstract]   [Full Text] [Related]  

  • 20. [Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes].
    Krempf M
    Nephrol Ther; 2006 May; 2 Suppl 3():S190-2. PubMed ID: 17370849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.